SCHEMBL8260719

SCHEMBL8260719

CC1CCC(NC(=O)OC(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.48
HSD11B1 P28845 1/20 0.43
DRD2 P14416 1/20 0.42
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
GAA P10253 2/20 0.38
ALDH1A1 P00352 4/20 0.37
ADRA2A P08913 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TAS1R3 Q7RTX0 2/20 0.37
TAS1R1 Q7RTX1 2/20 0.37
TAS1R2 Q8TE23 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPK1 P28482 1/20 0.36
MMP2 P08253 1/20 0.36
MMP8 P22894 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25486735 1.00 EPHX1 (0.48) EPHX1HSD11B1DRD2MEN1LMNA
SCHEMBL103089 0.92 HSD11B1 (0.47) EPHX1HSD11B1DRD2RAB9ANPC1
Bicarbonate SCHEMBL8027977 0.88 HSD11B1 (0.44) EPHX1HSD11B1DRD2RAB9ANPC1
SCHEMBL12283083 0.85 EPHX2 (0.52) EPHX1HSD11B1DRD2RAB9ANPC1
SCHEMBL12282654 0.84 EPHX1 (0.52) EPHX1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL12206723 0.84 EPHX1 (0.47) EPHX1HSD11B1DRD2RAB9ANPC1
SCHEMBL18814221 0.83 HSD11B1 (0.42) EPHX1HSD11B1DRD2KMT2ASMN1; SMN2
SCHEMBL13998252 0.83 SMYD3 (0.49) EPHX1HSD11B1DRD2
SCHEMBL18814220 0.83 HSD11B1 (0.42) EPHX1HSD11B1DRD2KMT2ASMN1; SMN2
SCHEMBL25480124 0.82 EPHX1 (0.55) EPHX1RAB9ANPC1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461328-B2 Tricyclic heterocyclic compounds, compositions and methods of use thereof GENENTECH, INC. (US) 2013-06-11 US disclosed
WO-2006097293-A2 COMBINATION OF A STEROID SULFATASE INHIBITOR AND AN ASCOMYCIN NOVARTIS AG (CH) 2006-09-21 WO disclosed